Kallyope
Focusing on Big Health Challenges That Matter
New York, United States · Founded 2015 · $487.2M raised
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- kallyope.com
- Total Funding
- $487.2M
- Last Round
- $8.2M GrantMay 2023
- Rounds
- 6
About
Founded in 2015 by world-leading neuroscientists, Kallyope uses its Klarity platform to target the gut-brain axis for neurological and metabolic diseases. The late-stage pipeline includes acute migraine treatments and novel metabolism programs entering clinical studies in 2026.
Summary
Kallyope is a Biotech company based in New York, United States, founded in 2015. It has raised $487.2M in total across 6 rounds, most recently a $8.2M Grant round in May 2023. Investors include Bill & Melinda Gates Foundation, Lux Capital and Polaris Partners.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2023
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Bill & Melinda Gates Foundation
3 rounds
Lux Capital
3 rounds
Polaris Partners
3 rounds
Casdin Capital
2 rounds
Two Sigma Ventures
2 rounds
Mubadala Investment Company
1 round
The Column Group
1 round
Greenspring
1 round
Alexandria Venture Investments
3 rounds
Illumina Ventures
3 rounds
Euclidean Capital
2 rounds
DNS Capital
1 round
Hartford Healthcare Endowment
1 round
Parkwood
1 round
Tao Capital Partners
1 round
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...